Ranitidina
Modo de Uso[editar]
75 y 150 mg [2] FDA está retirando partida por contenido de NDMA [3] Por razones similares, el año anterior se había retirado voluntariamente valsartán del mercado japonés[4]
Enlaces[editar]
https://www.ema.europa.eu/en/news/ema-review-ranitidine-medicines-following-detection-ndma PDF
Notas[editar]
- ↑ comunicado de prensa del ISP
- ↑ FDA recalls ranitidine medicines over potential cancer causing impurity
- ↑ Formation mechanism of NDMA from ranitidine, trimethylamine, and other tertiary amines during chloramination: a computational study
- ↑ Rapid and efficient high-performance liquid chromatography analysis of N-nitrosodimethylamine impurity in valsartan drug substance and its products